Theodore Levin to Occult Blood
This is a "connection" page, showing publications Theodore Levin has written about Occult Blood.
Connection Strength
5.723
-
Performance of a quantitative fecal immunochemical test for detecting advanced colorectal neoplasia: a prospective cohort study. BMC Cancer. 2018 May 02; 18(1):509.
Score: 0.562
-
Association Between Time to Colonoscopy After a Positive Fecal Test Result and Risk of Colorectal Cancer and Cancer Stage at Diagnosis. JAMA. 2017 Apr 25; 317(16):1631-1641.
Score: 0.524
-
In simulation modelling, there are multiple ways to effectively screen for colorectal cancer. Evid Based Med. 2017 04; 22(2):59.
Score: 0.513
-
Fecal Immunochemical Test (FIT) for Colon Cancer Screening: Variable Performance with Ambient Temperature. J Am Board Fam Med. 2016 11 12; 29(6):672-681.
Score: 0.508
-
Colorectal-cancer screening--coming of age. N Engl J Med. 2013 Sep 19; 369(12):1164-6.
Score: 0.408
-
The importance of choosing colorectal cancer screening tests: comment on "Adherence to colorectal cancer screening". Arch Intern Med. 2012 Apr 09; 172(7):582-3.
Score: 0.369
-
Editorial: It's time to make organized colorectal cancer screening convenient and easy for patients. Am J Gastroenterol. 2009 Apr; 104(4):939-41.
Score: 0.299
-
Fecal Immunochemical Test Screening and Risk of Colorectal Cancer Death. JAMA Netw Open. 2024 Jul 01; 7(7):e2423671.
Score: 0.215
-
Factors associated with colorectal cancer screening in a population-based study: the impact of gender, health care source, and time. Prev Med. 2004 Mar; 38(3):276-83.
Score: 0.210
-
Mailed fecal immunochemical test outreach for colorectal cancer screening: Summary of a Centers for Disease Control and Prevention-sponsored Summit. CA Cancer J Clin. 2020 07; 70(4):283-298.
Score: 0.163
-
Influence of Varying Quantitative Fecal Immunochemical Test Positivity Thresholds on Colorectal Cancer Detection. Ann Intern Med. 2019 05 21; 170(10):736-737.
Score: 0.151
-
Effects of Organized Colorectal Cancer Screening on Cancer Incidence and Mortality in a Large Community-Based Population. Gastroenterology. 2018 11; 155(5):1383-1391.e5.
Score: 0.143
-
Interventions to Improve Follow-up of Positive Results on Fecal Blood Tests: A Systematic Review. Ann Intern Med. 2017 Oct 17; 167(8):565-575.
Score: 0.135
-
Time to Diagnostic Testing After a Positive Colorectal Cancer Screening Test. JAMA. 2017 08 01; 318(5):483.
Score: 0.133
-
Colorectal Cancer Screening: Recommendations for Physicians and Patients From the U.S. Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017 07; 153(1):307-323.
Score: 0.132
-
Colorectal cancer screening: Recommendations for physicians and patients from the U.S. Multi-Society Task Force on Colorectal Cancer. Gastrointest Endosc. 2017 07; 86(1):18-33.
Score: 0.132
-
Beyond Colonoscopy: The Role of Alternative Screening Tests for Colorectal Cancer in Your Practice. Am J Gastroenterol. 2017 01; 112(1):8-10.
Score: 0.127
-
Recommendations on fecal immunochemical testing to screen for colorectal neoplasia: a consensus statement by the US Multi-Society Task Force on colorectal cancer. Gastrointest Endosc. 2017 Jan; 85(1):2-21.e3.
Score: 0.126
-
Fecal Immunochemical Test Program Performance Over 4 Rounds of Annual Screening: A Retrospective Cohort Study. Ann Intern Med. 2016 Apr 05; 164(7):456-63.
Score: 0.120
-
Automated phone and mail population outreach to promote colorectal cancer screening. Am J Manag Care. 2012 Jul; 18(7):370-8.
Score: 0.094
-
Organized colorectal cancer screening in integrated health care systems. Epidemiol Rev. 2011; 33:101-10.
Score: 0.087
-
Stool DNA and occult blood testing for screen detection of colorectal neoplasia. Ann Intern Med. 2008 Oct 07; 149(7):441-50, W81.
Score: 0.072
-
Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics. J Natl Cancer Inst. 2007 Oct 03; 99(19):1462-70.
Score: 0.067
-
Unsatisfactory Fecal Immunochemical Tests for Colorectal Cancer Screening: Prevalence, Reasons, and Subsequent Testing. Cancer Epidemiol Biomarkers Prev. 2024 Feb 06; 33(2):215-223.
Score: 0.052
-
Flexible sigmoidoscopy: an important screening option for average-risk individuals. Gastrointest Endosc Clin N Am. 2002 Jan; 12(1):23-40, vi.
Score: 0.045
-
The effect of using fecal testing after a negative sigmoidoscopy on the risk of death from colorectal cancer. J Med Screen. 2021 06; 28(2):140-147.
Score: 0.040
-
Colorectal cancer screening: new opportunities. Surg Oncol Clin N Am. 1999 Oct; 8(4):673-91, vi-vii.
Score: 0.039
-
A Comparison of Fecal Immunochemical and High-Sensitivity Guaiac Tests for Colorectal Cancer Screening. Am J Gastroenterol. 2017 Nov; 112(11):1728-1735.
Score: 0.034
-
Colorectal Cancer Screening Initiation After Age 50 Years in an Organized Program. Am J Prev Med. 2017 Sep; 53(3):335-344.
Score: 0.033
-
Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2017 04; 152(5):1217-1237.e3.
Score: 0.032
-
Recommendations on Fecal Immunochemical Testing to Screen for Colorectal Neoplasia: A Consensus Statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol. 2017 01; 112(1):37-53.
Score: 0.032
-
Time to Colonoscopy after Positive Fecal Blood Test in Four U.S. Health Care Systems. Cancer Epidemiol Biomarkers Prev. 2016 Feb; 25(2):344-50.
Score: 0.030
-
Multitarget stool DNA testing for colorectal-cancer screening. N Engl J Med. 2014 Apr 03; 370(14):1287-97.
Score: 0.026
-
Accuracy of fecal immunochemical tests for colorectal cancer: systematic review and meta-analysis. Ann Intern Med. 2014 Feb 04; 160(3):171.
Score: 0.026
-
Effectiveness and reach of the FLU-FIT program in an integrated health care system: a multisite randomized trial. Am J Public Health. 2013 Jun; 103(6):1128-33.
Score: 0.025
-
Implications of new colorectal cancer screening technologies for primary care practice. Med Care. 2008 Sep; 46(9 Suppl 1):S138-46.
Score: 0.018